Testing effectiveness (Phase 2)UnknownNCT01027065
What this trial is testing
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Who this might be right for
Chronic Hepatitis B
Cytheris SA 24